Introducing CHATBOT — the latest innovation in our platform. Built with conversational AI, CHATBOT helps you move beyond search and manual review. You can now surface relevant insights, identify patterns, and extract key information — all through a seamless, intuitive experience. Experience faster, smarter pharmacovigilance with CHATBOT. [...]
Alwis Group is proud to be a Gold Sponsor at the upcoming WHY Summit – Future of Pharmacovigilance World Tour / World Drug Safety Summit in Basel, Switzerland. This global event will bring together leading experts and innovators to discuss the evolving landscape of drug safety and pharmacovigilance, aligning with [...]
ALWIS Group proudly participated in this high-impact summit focused on advancing drug safety through innovation and collaboration. The two-day event brought together global pharmacovigilance leaders, regulatory experts, and tech pioneers to discuss the evolving landscape of safety monitoring. At the heart of our presence was ReTrans Enterprise, our flagship AI-powered [...]
At the World Drug Safety Congress Europe, ALWIS Solutions Limited stands out as a Gold Sponsor, showcasing its commitment to advancing pharmacovigilance through innovative technology. With over a decade of experience in life sciences, ALWIS specializes in cloud-based platforms that streamline drug safety processes for pharmaceutical companies, Contract Research Organizations [...]
At the Global Drug Safety & PV Outsourcing Summit 2024 held in Mumbai, ALWIS Group participated as a Silver Sponsor, highlighting its commitment to advancing pharmacovigilance through innovative AI-driven solutions. While specific details of their presentation are not publicly available, ALWIS Group’s showcased products included: [...]
We’re proud to announce that a Fortune 500 pharmaceutical leader has officially gone live with ReTrans, our AI-driven literature surveillance platform. This milestone not only reinforces the growing global trust in ALWIS Group’s technological innovations but also showcases the scalability, compliance, and efficiency of ReTrans in enterprise pharmacovigilance environments. As [...]